The Pharmaceutical Journal speaks about P1vital® PReDicT Test
Posted 1st February 2018

The Pharmaceutical Journal speaks about P1vital® PReDicT Test

The Pharmaceutical Journal examines personalised treatment to depression including P1vital® PReDicT Test which is being used in the PReDicT randomised clinical trial across 5 European countries.

Read the full article
In other news
P1vital gains acceptance of the first PReDicT Study publication!
P1vital gains acceptance of the first PReDicT Study publication!
Read more
P1vital gains acceptance of the first PReDicT Study publication!
Find out how i-spero® can help your patients

If you are a primary care provider, or are responsible for the purchasing/commissioning of primary care or specialist mental health services we would welcome a discussion.